Zobrazeno 1 - 10
of 12
pro vyhledávání: '"John Y. Koo"'
Autor:
Mark G. Lebwohl, John Y. Koo, April W. Armstrong, Bruce E. Strober, George M. Martin, Nicole N. Rawnsley, Earl L. Goehring, Abby A. Jacobson
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1349-1357 (2024)
Abstract Introduction Brodalumab is a human interleukin-17 receptor A antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond o
Externí odkaz:
https://doaj.org/article/4d96df29b9fb43bc9db5f5236b669fdf
Autor:
John Y. Koo, Anh N. Tran
Publikováno v:
Psoriasis Forum. :8-15
Psoriasis is a common condition, often associated with substantial psychological morbidity. Stress is frequently implicated in the onset or exacerbation of psoriasis, giving rise to the possible use of psychotherapeutic modalities in treatment. This
Autor:
Jodie L, Sasaki, John Y, Koo
Publikováno v:
Clinical and experimental rheumatology. 33(5 Suppl 93)
Psoriasis is a common, chronic, inflammatory skin condition in which up to 42% of patients may develop psoriatic arthritis. Consequently, dermatologists and rheumatologists frequently manage the same patient for psoriasis and psoriatic arthritis, res
Autor:
Anh N, Tran, John Y, Koo
Publikováno v:
Journal of drugs in dermatology : JDD. 13(9)
The eutectic mixture of lidocaine and prilocaine (EMLA, APP Pharmaceuticals, LLC.) is an anesthetic cream frequently used by dermatologists. Although side effects of EMLA are usually mild local skin reactions (ie, edema, pallor, erythema), more sever
Autor:
John Y, Koo
Publikováno v:
Cutis. 79(1 Suppl 2)
Psoriasis is a chronic disease that requires lifelong treatment. Because there is no cure for psoriasis, treatment is aimed at inducing remission and reducing the impact of the disease on patients' lives. Despite the availability of several therapies
Publikováno v:
Skinmed. 4(6)
Tumor necrosis factor-alpha inhibitors are among the new class of drugs that offer new options for psoriasis control. In addition to serving as a key mediator in psoriasis, elevated tumor necrosis factor-alpha levels have also been observed in patien
Publikováno v:
Cutis. 76(3)
The association between alcohol and the development of plaque-type psoriasis is complex and confusing because many of the initial studies did not control for confounding factors such as tobacco use. This article presents a literature review of the ep
Autor:
Pooja, Khera, John Y, Koo
Publikováno v:
Journal of drugs in dermatology : JDD. 4(4)
Retinoids, a group of compounds encompassing Vitamin A and its analogs, have been shown to inhibit tumor growth in laboratory studies. Based on these findings, a number of clinical trials have been conducted to investigate the chemoprotective and che
Publikováno v:
Journal of drugs in dermatology : JDD. 4(2)
Cyclosporine is an immunosuppressive agent that has been shown to be effective in the treatment of psoriasis. However, its serious side effects in transplant patients have hindered many dermatologists from exploiting its therapeutic capabilities. The
Autor:
Aparche, Yang, John Y, Koo
Publikováno v:
Journal of drugs in dermatology : JDD. 3(2)
A significant proportion of patients seen by dermatologists have skin disease complicated by a psychiatric condition. These conditions often give rise to social, legal, and ethical concerns which impede the proper treatment of these patients, commonl